Readability User Testing
Readability User Testing
When it comes to patient safety, clarity is everything. EU regulations require that every approved medicinal product and many medical devices include a package leaflet that is clear, accessible, and easily understood by the end user.
At PharmaAS, we bridge the resource gap for organisations by providing a bespoke, end-to-end testing service tailored to your project timelines.
Why Readability Matters
Our process confirms that patients and healthcare providers can:
- Quickly Locate: Find key information within the leaflet immediately.
- Clearly Understand: Interpret the text and visuals without confusion.
- Correctly Act: Take the right action based on what they have read.
Our Specialised Approach
We offer efficient solutions designed to meet regulatory obligations with confidence:
Full Readability Studies:
Complete, end-to-end testing services that ensure full compliance with competent authorities.
Bridging Strategies:
If you have a generic product, a full study may not be required. We identify relevant Package Information Leaflets (PIL) and author the necessary Bridging Reports to save you time and cost.
Regulatory Alignment:
We ensure all information, both text and visuals, is prepared for approval by the relevant authorities.
Cost-Effective & Compliant. We ensure your patient information is not just a document, but a clear guide for safe use.